San Diego, CA, United States of America

Weixian Xi

This inventor holds 4 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: Illumina Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Weixian Xi. Retrieved from https://idiyas.com/inventor/weixian-xi-1ar663gn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 50.0

 

Average Co-Inventor Count = 4.9

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Weixian Xi - Innovator in Biotechnology

Introduction

Weixian Xi is an accomplished inventor based in San Diego, California. He is currently associated with Illumina Corporation, a leading company in the field of genomics. Although he has not yet been granted any patents, his work focuses on innovative methods in biotechnology.

Latest Patent Applications

Weixian Xi has submitted several notable patent applications, including:

1. **Capturing and Amplifying Polynucleotides** - This application describes a structure that interacts with polynucleotides of varying lengths, each containing first and second adapters. The structure features a substrate with two regions separated by a gap of at least 100 nm. Capture primers are coupled to both regions, allowing for the amplification of sufficiently long polynucleotides while excluding shorter ones.

2. **Preparing Features on a Substrate Using Nano-Imprint Lithography** - This application outlines a method involving the placement of a hydrogel within a recess of a substrate. The process includes the removal of a pillar and the subsequent placement of a second hydrogel in a separate recess, demonstrating innovative techniques for forming patterned hydrogels.

Conclusion

Weixian Xi is a promising inventor whose contributions to biotechnology are reflected in his latest patent applications. His work at Illumina Corporation showcases his commitment to advancing the field of genomics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…